Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacokinetics of Intraperitoneal and Intravenous Meropenem, Ampicillin, Aztreonam and Ciprofloxacin in Automated Peritoneal Dialysis Patients Without Peritonitis

NCT07113587 is registered in ClinicalTrials.gov with Karl Landsteiner Insitute for Nephrology and Haemato-Oncology as lead sponsor.

NCT NCT07113587
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07113587 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacokinetics of Intraperitoneal and Intravenous Meropenem, Ampicillin, Aztreonam and Ciprofloxacin in Automated Peritoneal Dialysis Patients Without Peritonitis
Lead sponsor
Karl Landsteiner Insitute for Nephrology and Haemato-Oncology
Phase
Phase 2/3
Overall status
Completed
Start date
April 8, 2014
Completion date
July 7, 2017
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ampicillin, aztreonam, ciprofloxacin, intraperitoneal, intravenous, intravenous administration, meropenem, minimum inhibitory concentration (mic), peritoneal dialysis (pd), peritoneal dialysis-associated peritonitis, pharmacokinetics